Cargando…
Methods to Produce Monoclonal Antibodies for the Prevention and Treatment of Viral Infections
A viral threat can arise suddenly and quickly turn into a major epidemic or pandemic. In such a case, it is necessary to develop effective means of therapy and prevention in a short time. Vaccine development takes decades, and the use of antiviral compounds is often ineffective and unsafe. A quick r...
Autores principales: | Merkuleva, Yu. A., Shcherbakov, D. N., Ilyichev, A. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Pleiades Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134727/ https://www.ncbi.nlm.nih.gov/pubmed/35637780 http://dx.doi.org/10.1134/S1068162022020169 |
Ejemplares similares
-
Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
por: Shcherbakov, D. N., et al.
Publicado: (2015) -
Antibody therapies for the prevention and treatment of viral infections
por: Salazar, Georgina, et al.
Publicado: (2017) -
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections
por: Mokhtary, Pardis, et al.
Publicado: (2022) -
Monoclonal antibodies for malaria prevention
por: Aleshnick, Maya, et al.
Publicado: (2022) -
Model systems of human immunodef iciency virus (HIV-1) for in vitro eff icacy assessment of candidate vaccines and drugs against HIV-1
por: Rudometova, N.B., et al.
Publicado: (2022)